Rohit Upadhyay
- Cancer Research top 10%
-
- RNA modifications and cancer 5
- Glutathione Transferases and Polymorphisms 4
- Genomics, phytochemicals, and oxidative stress 3
- Epigenetics and DNA Methylation 3
-
- Esophageal Cancer Research and Treatment 8
- Urinary and Genital Oncology Studies 4
-
- Lung Cancer Treatments and Mutations 4
-
- Urological Disorders and Treatments 4
- Co-authors
- Balraj MittalUday C. GhoshalShaleen KumarMeenu JainMeenakshi UmarManzoor Ahmad MalikRama Devi MittalVecihi Batuman
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Scientific Reports (2 papers)
- Partner nations
- IndiaUnited StatesQatar
In The Last Decade
Rohit Upadhyay
41 papers receiving 732 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 169
- Molecular Biology 447
- Oncology 146
- Pharmacology 40
- Surgery 186
Countries citing papers authored by Rohit Upadhyay
This map shows the geographic impact of Rohit Upadhyay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohit Upadhyay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohit Upadhyay more than expected).
Fields of papers citing papers by Rohit Upadhyay
This network shows the impact of papers produced by Rohit Upadhyay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohit Upadhyay. The network helps show where Rohit Upadhyay may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rohit Upadhyay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2020 | 15 | |
| 6 | Assessment on risk factors and incidence of renal stones | 2019 | 0 |
| 7 | 2019 | 15 | |
| 8 | 2014 | 8 | |
| 9 | 2014 | 36 | |
| 10 | 2012 | 31 | |
| 11 | 2012 | 16 | |
| 12 | 2012 | 19 | |
| 13 | 2012 | 6 | |
| 14 | 2011 | 16 | |
| 15 | 2010 | 17 | |
| 16 | 2010 | 47 | |
| 17 | 2009 | 49 | |
| 18 | 2009 | 9 | |
| 19 | 2008 | 18 | |
| 20 | 2007 | 31 |
About Rohit Upadhyay
Rohit Upadhyay is a scholar working on Urology, Health Informatics and Cancer Research, having authored 49 papers that have together received 743 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (8 papers), RNA modifications and cancer (5 papers), Lung Cancer Treatments and Mutations (4 papers), Glutathione Transferases and Polymorphisms (4 papers), Urinary and Genital Oncology Studies (4 papers), Urological Disorders and Treatments (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (169 citations), Molecular Biology (447 citations) and Oncology (146 citations). Rohit Upadhyay has collaborated with scholars based in India, United States and Qatar. Frequent co-authors include Balraj Mittal, Uday C. Ghoshal, Shaleen Kumar, Meenu Jain, Meenakshi Umar, Manzoor Ahmad Malik, Shaleen Kumar, Balraj Mittal, Rama Devi Mittal and Vecihi Batuman. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.